Jevtana IV infusion 60mg (YJ code: 4240410A1020) is an intravenous infusion manufactured by Sanofi, containing Cabazitaxel acetone adduct. It is supplied as 60mg x 1.5mL x 1 bottle with dissolving solution, indicated for specific cancer treatments, particularly metastatic prostate cancer.
Jevtana IV infusion 60mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).